Detection of Partial AZFc Microdeletions in Azoospermic Infertile Men Is Not Informative of MicroTESE Outcome

Authors

  • Azadeh Ghaheri Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
  • Azam Miraghazadeh 1, 4 Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences & Technology, Science and Research Branch, Islamic Azad University ,Tehran Iran (IAUPS)
  • Fakhredin Reihani-Sabet 4Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
  • Mohammad Ali Sadighi Gilani Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
  • Mohammadreza Zamanian Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
  • Parnaz Borjian Boroujeni Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
Abstract:

Objective microdeletions of Yq chromosome are the most frequent molecular genetics etiology for the male infertility which usually spans AZFa (azoo spermia factor a), AZFb and AZFc regions. Microdeletions are mostly seen in AZFc region and usually cover genes actively involved in spermatogenesis. Partial AZFc microdeletion may also happen with various spans namely gr/gr, b2/b3 and b1/b3. It is known that the micro TESE outcomes as the surgical process for sperm retrieval from the testis in infertile azoospermic men, can be predetermined based on the type of AZF microdeletion. Present study was aimed to evaluate the correlation between partial AZFc microdeletions and micro TESE results. MaterialsAndMethods In this descriptive study, 200 infertile azoospermic men referred to Royan institute were evaluated for the presence of partial AZFc microdeletions before they undergo micro TESE. Partial AZFc microdeletions were examined through multiplex PCR reactions using seven different STS markers. The data was analyzed by Chi-square (X2) statistical test. Results Among 90 patients (45%) with positive micro TESE results, 9 (10%) showed partial microdeletion in AZFc region. From 110 (55%) patients with negative micro TESE results, 7 (6.3%) had AZC partial microdeletion. Among 200 patients, 16 (8%) showed AZFc partial microdeletions including 11 (5.5%) of gr/gr and 5 (2.5%) of b2/b3. Statistical analysis showed no significant difference on micro TESE results between the patients with and without partial AZFc microdeletions. Conclusion Partial AZfc microdeletions may not be a determinant of the micro TESE results in azospermic men.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Frequency of Y Chromosome Microdeletions in Azoospermic and Oligospermic Iranian Infertile Men

Background and Aims: Azoospermia factor (AZF) region of the Y-chromosome has several genes which are responsible for normal spermatogenesis. Microdeletions of these genes are associated with azoospermia and oligospermia. These microdeletions are too small to be detected by karyotyping. They can be easily identified using polymerase chain reaction. The aim of this study is to determine the frequ...

full text

Molecular Study of Partial Deletions of AZFc Region of the Y Chromosome in Infertile Men

Background & Aims: The most significant cause of infertility in men is the genetic deletion in the azoospermia factor (AZF) region that is caused by the process of intra- and inter-chromosomal homologous recombination in amplicons. Homologous recombination could also result in partial deletions in AZF region. The aim of this research was to determine the association between the partial AZFc del...

full text

Partial AZFc deletions in infertile men with cryptorchidism.

BACKGROUND A specific type of partial AZFc deletion, called 'gr/gr' deletion, was recently proposed as genetic risk factor for spermatogenic impairment and testis cancer. Since both pathologies can be part of the testicular dysgenesis syndrome (TDS), we aimed to define the role of 'gr/gr' deletion in the aethiopathogenesis of another component of the TDS: cryptorchidism. METHODS A total of 14...

full text

AZF microdeletions and partial deletions of AZFc region on the Y chromosome in Moroccan men.

AIM To evaluate for the first time the frequency of Y chromosome microdeletions and the occurrence of the partial deletions of AZFc region in Moroccan men, and to discuss the clinical significance of AZF deletions. METHODS We screened Y chromosome microdeletions and partial deletions of the AZFc region of a consecutive group of infertile men (n = 149) and controls (100 fertile men, 76 normosp...

full text

Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions.

BACKGROUND Y chromosome microdeletions are associated with severe male factor infertility. In this study, the success rate of testicular sperm retrieval was determined for men with deletions of AZF regions a, b or c. METHODS AZF deletions were detected by PCR of 30 sequence-tagged sites within Yq emphasizing the AZFa, b and c regions. Semen analysis and diagnostic testis biopsy or testicular ...

full text

Detection of Y Chromosome Microdeletions and Hormonal Profile Analysis of Infertile Men undergoing Assisted Reproductive Technologies

Objective Y chromosome deletions (YCDs) in azoospermia factor (AZF) region are associated with abnormal spermatogenesis and may lead to azoospermia or severe oligozoospermia. Assisted reproductive technologies (ART) by intracytoplasmic sperm injection (ICSI) and testicular sperm extraction (TESE) are commonly required for infertility management of patients carrying YCDs. The aim of this study w...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 12  issue 4

pages  298- 302

publication date 2019-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023